search
Back to results

Risk of Pneumothorax With and Without Chest Tube Clamping in Patients With Pleural Pathology

Primary Purpose

Pneumothorax, Chest Tube, Pleural Diseases

Status
Completed
Phase
Not Applicable
Locations
Mexico
Study Type
Interventional
Intervention
Clamping
Non Clampling
Sponsored by
National Institute of Respiratory Diseases, Mexico
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pneumothorax focused on measuring Chest tube, Pneumothorax, Pleural Diseases

Eligibility Criteria

16 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients aged 16 years and more.
  • Patients hospitalized in the National Institute of Respiratory Diseases.
  • Patients who had a chest tube placement during their stay at the hospital, by any cause.

Exclusion Criteria:

  • Patients who refuse to sign the informed consent and who refuse to participate in the study.
  • Patients who die before randomization.
  • Patients who gets chest tube removal before being randomized.

Sites / Locations

  • National Institute of Respiratory Diseases

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Sham Comparator

Arm Label

Patients with clamping of the chest tube

Patients without clamping of the chest tube

Arm Description

Patients with 6hour clamping prior to removal

Patients will have chest tube removed immediately

Outcomes

Primary Outcome Measures

Incidence of pneumothorax after chest tube removal with chest tube clamping
Cases of pneumothorax after chest tube removal despite clamping
Incidence of pneumothorax after chest tube removal without chest tube clamping
Cases of pneumothorax after chest tube removal despite clamping

Secondary Outcome Measures

Hospital days of stay
Hospital days of stay

Full Information

First Posted
January 31, 2022
Last Updated
May 30, 2023
Sponsor
National Institute of Respiratory Diseases, Mexico
search

1. Study Identification

Unique Protocol Identification Number
NCT05243316
Brief Title
Risk of Pneumothorax With and Without Chest Tube Clamping in Patients With Pleural Pathology
Official Title
Risk of 24 Hour-pneumothorax After Chest Tube Removal With and Without Chest Tube Clamping in Patients With Pleural Pathology at the National Institute of Respiratory Diseases
Study Type
Interventional

2. Study Status

Record Verification Date
February 2022
Overall Recruitment Status
Completed
Study Start Date
December 22, 2021 (Actual)
Primary Completion Date
March 31, 2023 (Actual)
Study Completion Date
April 15, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
National Institute of Respiratory Diseases, Mexico

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Through this randomized controlled clinical trial, we aim to identify whether there is a difference in the incidence of 24 hour pneumothorax after chest tube removal, in two blindly randomized groups of patients: The first group with chest tube clamping 6 hours prior to removal, and the second group there will be no chest tube clamping. The data will be prospectively collected from patient records from the National Institute of Respiratory Diseases Ismael Cosío Villegas.
Detailed Description
Patients with an indication of chest tube removal will be randomized to two possible arms: clamping (for 6 hours before removal) or not clamping (immediate removal). Incidence of 24hour pneumothorax after chest tube removal will be recorded.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pneumothorax, Chest Tube, Pleural Diseases
Keywords
Chest tube, Pneumothorax, Pleural Diseases

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled trial
Masking
Outcomes Assessor
Masking Description
Randomizing will be masked, as well as data analysis.
Allocation
Randomized
Enrollment
93 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Patients with clamping of the chest tube
Arm Type
Active Comparator
Arm Description
Patients with 6hour clamping prior to removal
Arm Title
Patients without clamping of the chest tube
Arm Type
Sham Comparator
Arm Description
Patients will have chest tube removed immediately
Intervention Type
Procedure
Intervention Name(s)
Clamping
Intervention Description
There will be a randomized selection of patients who will have a clamping of the chest tube 6 hours prior to chest tube removal.
Intervention Type
Procedure
Intervention Name(s)
Non Clampling
Intervention Description
There will be a randomized selection of patients who wont have chest tube clamping 6 hours prior to chest tube removal.
Primary Outcome Measure Information:
Title
Incidence of pneumothorax after chest tube removal with chest tube clamping
Description
Cases of pneumothorax after chest tube removal despite clamping
Time Frame
After 24 hours of procedure
Title
Incidence of pneumothorax after chest tube removal without chest tube clamping
Description
Cases of pneumothorax after chest tube removal despite clamping
Time Frame
After 24 hours of procedure
Secondary Outcome Measure Information:
Title
Hospital days of stay
Description
Hospital days of stay
Time Frame
Through study completion, an average of 1 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients aged 16 years and more. Patients hospitalized in the National Institute of Respiratory Diseases. Patients who had a chest tube placement during their stay at the hospital, by any cause. Exclusion Criteria: Patients who refuse to sign the informed consent and who refuse to participate in the study. Patients who die before randomization. Patients who gets chest tube removal before being randomized.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sebastian Rodriguez, Doctor
Organizational Affiliation
National Institute of Respiratory Diseases
Official's Role
Study Director
Facility Information:
Facility Name
National Institute of Respiratory Diseases
City
Mexico City
ZIP/Postal Code
14080
Country
Mexico

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Database will be available once the protocol is complete
IPD Sharing Time Frame
Once completed for one year
IPD Sharing Access Criteria
Free access

Learn more about this trial

Risk of Pneumothorax With and Without Chest Tube Clamping in Patients With Pleural Pathology

We'll reach out to this number within 24 hrs